HistoSonics
Develops non-invasive sonic beam therapy for destroying targeted tumors.
medical-devices
Company facts
- Founded
- 2009
- Employees
- 357
- Headquarters
- United States
- Type
- Private
- Funding
- Series E · $250M · 2025
Open positions
1 job
7 views last month
Sr. Supplier Quality Engineer
Open 32d North AmericaFull-timeSenior
United States
Plymouth, MNHistoSonics is a commercial-stage medtech company advancing the Edison® System, a novel non-invasive sonic beam therapy based on histotripsy. Since receiving FDA De Novo grant for the non-invasive destruction of liver…
FMEA Iso 13485